Reuters logo
BRIEF-Ajanta Pharma gets USFDA nod for Duloxetine Hydrochloride delayed release capsules
January 9, 2017 / 10:11 AM / 8 months ago

BRIEF-Ajanta Pharma gets USFDA nod for Duloxetine Hydrochloride delayed release capsules

Jan 9 (Reuters) - Ajanta Pharma Ltd :

* Says Ajanta Pharma announces US FDA approval for Duloxetine Hydrochloride delayed release capsules

* Says company will be launching the product shortly in 3 strengths, 20 mg, 30 mg and 60 mg strengths capsules Source text: bit.ly/2i9tdsI Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below